US Patent:
20080171773, Jul 17, 2008
Inventors:
Jeremy John Edmunds - Acton MA, US
Brian Matthew Samas - New London CT, US
International Classification:
A61K 31/4439
C07D 401/02
A61P 7/00
A61P 35/04
Abstract:
(R)-5-Methyl-4,5-dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} pharmaceutical compositions, methods and methods of using the compound or pharmaceutical compositions thereof to treat diseases characterized by abnormal thrombosis in mammals. Crystalline form of (R)-5-Methyl-4,5-dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)amide]5-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}
